BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2026 8:21:22 AM | Browse: 0 | Download: 0
 |
Received |
|
2026-02-14 01:58 |
|
Peer-Review Started |
|
2026-02-14 02:01 |
|
First Decision by Editorial Office Director |
|
2026-03-26 10:14 |
|
Return for Revision |
|
2026-03-26 10:14 |
|
Revised |
|
2026-03-30 15:06 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-04-27 02:34 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-05-07 07:47 |
|
Articles in Press |
|
2026-05-07 07:47 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-26 09:33 |
|
Publish the Manuscript Online |
|
2026-06-25 08:21 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Ophthalmology |
| Manuscript Type |
Minireviews |
| Article Title |
Stem cells in managing glaucoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Francesco Cappellani, Matteo Capobianco, Federico Visalli, Alessandro Avitabile, Giuseppe Gagliano, Simonetta Gaia Nicolosi, Marieme Khouyyi, Fabiana D’Esposito, Caterina Gagliano and Marco Zeppieri |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marco Zeppieri, Consultant, MD, PhD, Postdoc, Department of Ophthalmology, University Hospital of Udine, p. le S. Maria della Misericordia 15, Udine 33100, Italy. mark.zeppieri@asufc.sanita.fvg.it |
| Key Words |
Stem cells; Retinal ganglion cells; Glaucoma; Neuroprotection; Induced pluripotent stem cells; Regenerative medicine; Mesenchymal stem cells |
| Core Tip |
Glaucoma is widely acknowledged as a chronic neurodegenerative condition characterized by irreversible loss of retinal ganglion cells, leading to progressive visual deterioration despite good management of intraocular pressure. Stem cell-based approaches present an innovative regenerative framework by delivering neurotrophic support, immunomodulation, and possible cellular replacement. Experimental studies indicate that embryonic, induced pluripotent, and mesenchymal stem cells can extend the survival of retinal ganglion cells and alter the glaucomatous milieu. Despite significant obstacles, stem cell technologies may eventually enhance or transform existing glaucoma treatment protocols. |
| Publish Date |
2026-06-25 08:21 |
| Citation |
Cappellani F, Capobianco M, Visalli F, Avitabile A, Gagliano G, Nicolosi SG, Khouyyi M, D’Esposito F, Gagliano C, Zeppieri M. Stem cells in managing glaucoma. World J Stem Cells 2026; 18(6): 120083
|
| URL |
https://www.wjgnet.com/1948-0210/full/v18/i6/120083.htm |
| DOI |
https://doi.org/10.4252/wjsc.120083 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
